On the public citation graph
Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification
0 signed · 3748 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.3858818openalex-extracted
A New Prognostic Model for Radiation-Based Hepatocellular Carcinoma Treatment
inferred← citeshttps://doi.org/10.2139/ssrn.4120417openalex-extracted
A Prospective Study for Validation of General Evaluation Score for Hepatocellular Carcinoma Risk Stratification in Chronic Hepatitis C Patients
inferred← citeshttps://doi.org/10.2139/ssrn.4191377openalex-extracted
Efficacy of Radiofrequency Ablation Following Transarterial Chemoembolization Combined with Sorafenib for Intermediate Stage Recurrent Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.2139/ssrn.4585233openalex-extracted
A Prognostic Model for Unresectable Hepatocellular Carcinoma Treated with Dual PD-1 and Angiogenesis Blockadetherapy
inferred← citeshttps://doi.org/10.2139/ssrn.4834019openalex-extracted
Cost-Effectiveness of the Clinical Management of Hepatocellular Carcinoma in Four Asian-Pacific Countries
inferred← citeshttps://doi.org/10.1001/archsurg.2008.511openalex-snapshot
Risk Factors and Management of Ascites After Liver Resection to Treat Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2021.25055openalex-snapshot
Development and Validation of a Model Including Distinct Vascular Patterns to Estimate Survival in Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2025.32353openalex-snapshot
Machine Learning–Based Selection of Resection vs Transplant and Survival in Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1001/jamasurg.2016.1121openalex-snapshot
Hierarchic Interaction of Factors Associated With Liver Decompensation After Resection for Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1002/14651858.cd011649openalex-snapshot
Management of people with intermediate-stage hepatocellular carcinoma: a network meta-analysis
inferred← citeshttps://doi.org/10.1002/14651858.cd011649.pub2openalex-snapshot
Management of people with intermediate-stage hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/14651858.cd011650openalex-snapshot
Management of people with early or very early stage hepatocellular carcinoma: a network meta-analysis
inferred← citeshttps://doi.org/10.1002/14651858.cd011650.pub2openalex-snapshot
Management of people with early- or very early-stage hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/14651858.cd013346openalex-snapshot
Abdominal ultrasound and alpha-fetoprotein for the diagnosis of hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/14651858.cd013346.pub2openalex-snapshot
Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease
inferred← citeshttps://doi.org/10.1002/14651858.cd013362openalex-snapshot
Computed tomography for the diagnosis of hepatocellular carcinoma in chronic advanced liver disease
inferred← citeshttps://doi.org/10.1002/14651858.cd013362.pub2openalex-snapshot
Computed tomography for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease
inferred← citeshttps://doi.org/10.1002/14651858.cd013483openalex-snapshot
Contrast-enhanced ultrasound for the diagnosis of hepatocellular carcinoma in advanced chronic liver disease
inferred← citeshttps://doi.org/10.1002/14651858.cd013483.pub2openalex-snapshot
Contrast-enhanced ultrasound for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease
inferred← citeshttps://doi.org/10.1002/14651858.cd014798openalex-snapshot
Magnetic resonance imaging for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease
inferred← citeshttps://doi.org/10.1002/14651858.cd014798.pub2openalex-snapshot
Magnetic resonance imaging for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease
inferred← citeshttps://doi.org/10.1002/1878-0261.13154openalex-snapshot
Epigenetic priming in chronic liver disease impacts the transcriptional and genetic landscapes of hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/2211-5463.12774openalex-snapshot
Silencing of IL13RA2 promotes partial epithelial‐mesenchymal transition in hepatocellular carcinoma via ERK signaling pathway activation
inferred← citeshttps://doi.org/10.1002/9780470691861.ch5gopenalex-snapshot
Interventional Radiology in Hepatobiliary Diseases
inferred← citeshttps://doi.org/10.1002/9780470747919.ch66openalex-snapshot
The Hepatocyte and the Cancer Cell: Dr Jekyll and Mr Hyde
inferred← citeshttps://doi.org/10.1002/9780470987131.ch48openalex-snapshot
Management of Hepatocellular Cancer
inferred← citeshttps://doi.org/10.1002/9781118637272.ch40openalex-snapshot
Management of Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1002/9781118781166.ch12openalex-snapshot
Oncological management of primary liver cancer in the era of minimal access surgery
inferred← citeshttps://doi.org/10.1002/9781119000822.hfcm092openalex-snapshot
Primary Neoplasms of the Liver
inferred← citeshttps://doi.org/10.1002/9781119000822.hfcm092.pub2openalex-snapshot
Primary Neoplasms of the Liver
inferred← citeshttps://doi.org/10.1002/9781119127437.ch89openalex-snapshot
Primary Carcinoma of the Liver
inferred← citeshttps://doi.org/10.1002/9781119211419.ch45openalex-snapshot
Hepatocellular Carcinoma: Diagnosis and Prognosis
inferred← citeshttps://doi.org/10.1002/9781119237662.ch36openalex-snapshot
Primary Malignant Neoplasms of the Liver
inferred← citeshttps://doi.org/10.1002/9781119756422.ch18openalex-snapshot
The Multidisciplinary Management of Primary Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1002/9781119962205.ch11openalex-snapshot
Comparative Performances of Staging Systems for Hepatocellular Cancer: Early HCC Considerations
inferred← citeshttps://doi.org/10.1002/9781444317053.ch31openalex-snapshot
Signaling Pathways and Rationale for Molecular Therapies in Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1002/9781444322682.ch17openalex-snapshot
Hepatobiliary Malignancies
inferred← citeshttps://doi.org/10.1002/9781444341294.ch35openalex-snapshot
Primary Malignant Neoplasms of the Liver
inferred← citeshttps://doi.org/10.1002/ags3.12065openalex-snapshot
Current topics in the surgical treatments for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/ags3.12212openalex-snapshot
Perioperative and prognostic implication of albumin‐bilirubin‐ TNM score in Child‐Pugh class A hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/ags3.12251openalex-snapshot
Preoperative lymphocyte‐to‐monocyte ratio is useful for stratifying the prognosis of hepatocellular carcinoma patients with a low Cancer of the Liver Italian Program score undergoing curative resection
inferred← citeshttps://doi.org/10.1002/aid2.13275openalex-snapshot
Effectiveness of multimodality treatment for hepatocellular carcinoma patients with portal vein thrombosis: A real world experience
inferred← citeshttps://doi.org/10.1002/aid2.13363openalex-snapshot
Prognosis of patients with hepatocellular carcinoma: Sex does not matter
inferred← citeshttps://doi.org/10.1002/bjs.10831openalex-snapshot
Prediction of major complications after hepatectomy using liver stiffness values determined by magnetic resonance elastography
inferred← citeshttps://doi.org/10.1002/bjs.11153openalex-snapshot
Hepatectomy for hepatocellular carcinoma after perioperative management of portal hypertension
inferred← citeshttps://doi.org/10.1002/bjs.11524openalex-snapshot
Prognostic model for identifying candidates for hepatectomy among patients with hepatocellular carcinoma and hepatic vein invasion
inferred← citeshttps://doi.org/10.1002/bjs.4554openalex-snapshot
Critical evaluation of the different staging systems for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/bjs.4986openalex-snapshot
Risk of tumour seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/bjs.5198openalex-snapshot
Selection of patients with hepatocellular carcinoma for liver transplantation
inferred← citeshttps://doi.org/10.1002/bjs.7516openalex-snapshot
Safety of hepatic resection in overweight and obese patients with cirrhosis
inferred← citeshttps://doi.org/10.1002/bjs.7672openalex-snapshot
Value of hepatic venous pressure gradient measurement before liver resection for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/bjs.8951openalex-snapshot
Severity of portal hypertension and prediction of postoperative liver failure after liver resection in patients with Child–Pugh grade A cirrhosis
inferred← citeshttps://doi.org/10.1002/bjs.9864openalex-snapshot
Response to transarterial chemoembolization as a selection criterion for resection of hepatocellular carcinomas
inferred← citeshttps://doi.org/10.1002/bjs.9960openalex-snapshot
Radiofrequency ablation as an alternative to hepatic resection for single small hepatocellular carcinomas
inferred← citeshttps://doi.org/10.1002/cac2.12614openalex-snapshot
Partial hepatectomy versus interventional treatment in patients with hepatitis B virus‐related hepatocellular carcinoma and clinically significant portal hypertension: a randomized comparative clinical trial
inferred← citeshttps://doi.org/10.1002/cam4.1067openalex-snapshot
Genetic variants of cell cycle pathway genes predict disease‐free survival of hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/cam4.1493openalex-snapshot
Prognosis of patients with hepatocellular carcinoma treated with sorafenib: a comparison of five models in a large Canadian database
inferred← citeshttps://doi.org/10.1002/cam4.2006openalex-snapshot
Recognition of HER2 expression in hepatocellular carcinoma and its significance in postoperative tumor recurrence
inferred← citeshttps://doi.org/10.1002/cam4.2038openalex-snapshot
Liver Resection Versus Transarterial Chemoembolization for the Treatment of Intermediate-Stage Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1002/cam4.2251openalex-snapshot
The impact of socioeconomic status on outcomes in hepatocellular carcinoma: Inferences from primary insurance
inferred← citeshttps://doi.org/10.1002/cam4.2944openalex-snapshot
Nomograms to predict the long‐time prognosis in patients with alpha‐fetoprotein negative hepatocellular carcinoma following radical resection
inferred← citeshttps://doi.org/10.1002/cam4.2951openalex-snapshot
Treatment optimization for recurrent hepatocellular carcinoma: Repeat hepatic resection versus radiofrequency ablation
inferred← citeshttps://doi.org/10.1002/cam4.4448openalex-snapshot
Sarcopenia predicts an adverse prognosis in patients with combined hepatocellular carcinoma and cholangiocarcinoma after surgery
inferred← citeshttps://doi.org/10.1002/cam4.4763openalex-snapshot
Safety and efficacy of atezolizumab plus bevacizumab in elderly patients with hepatocellular carcinoma: A multicenter analysis
inferred← citeshttps://doi.org/10.1002/cam4.5145openalex-snapshot
Initial therapeutic results of atezolizumab plus bevacizumab for unresectable advanced hepatocellular carcinoma and the importance of hepatic functional reserve
inferred← citeshttps://doi.org/10.1002/cam4.5224openalex-snapshot
Treatment outcomes of advanced hepatocellular carcinoma in real‐life practice: Chemotherapy versus multikinase inhibitors
inferred← citeshttps://doi.org/10.1002/cam4.5495openalex-snapshot
New prognostic system based on inflammation and liver function predicts prognosis in patients with advanced unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab: A validation study
inferred← citeshttps://doi.org/10.1002/cam4.5529openalex-snapshot
Preoperative transcatheter arterial chemoembolization and prognosis of patients with solitary large hepatocellular carcinomas (≥5 cm): Multicenter retrospective study
inferred← citeshttps://doi.org/10.1002/cam4.5535openalex-snapshot
Adverse events as potential predictive factors of therapeutic activity in patients with unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab
inferred← citeshttps://doi.org/10.1002/cam4.5944openalex-snapshot
Low‐energy amplitude‐modulated electromagnetic field exposure: Feasibility study in patients with hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/cam4.6031openalex-snapshot
Establishment and application of a survival rate graph model based on biomarkers and imaging indexes after primary hepatocellular carcinoma resection
inferred← citeshttps://doi.org/10.1002/cam4.6033openalex-snapshot
Systemic treatment in patients with Child–Pugh B liver dysfunction and advanced hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/cam4.6089openalex-snapshot
Efficacy of fusion imaging for immediate post‐ablation assessment of malignant liver neoplasms: A systematic review
inferred← citeshttps://doi.org/10.1002/cam4.6124openalex-snapshot
Factors predictive of clinical outcome in advanced hepatocellular carcinoma patients receiving ramucirumab treatment: A real‐world experience
inferred← citeshttps://doi.org/10.1002/cam4.6422openalex-snapshot
Effect of PIVKA‐II and AFP secretion status on early recurrence of hepatocellular carcinoma after open and laparoscopic surgery
inferred← citeshttps://doi.org/10.1002/cam4.6654openalex-snapshot
The adverse characteristics of hepatocellular carcinoma in the non‐cirrhotic liver disproportionately disadvantage Black patients
inferred← citeshttps://doi.org/10.1002/cam4.6876openalex-snapshot
Serum CXCL10 levels at the start of the second course of atezolizumab plus bevacizumab therapy predict therapeutic efficacy in patients with advanced BCLC stage C hepatocellular carcinoma: A multicenter analysis
inferred← citeshttps://doi.org/10.1002/cam4.70633openalex-snapshot
Transarterial Chemoembolization With or Without Systemic Therapy for Unresectable Hepatocellular Carcinoma: A Retrospective Comparative Study
inferred← citeshttps://doi.org/10.1002/cam4.854openalex-snapshot
A ‐1573T>C SNP within the human TRAIL promoter determines TRAIL expression and HCC tumor progression
inferred← citeshttps://doi.org/10.1002/cld.129openalex-snapshot
Natural history and staging for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/cld.267openalex-snapshot
Evolución natural y estratificación del carcinoma hepatocelular
inferred← citeshttps://doi.org/10.1002/cncr.20426openalex-snapshot
Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey
inferred← citeshttps://doi.org/10.1002/cncr.21972openalex-snapshot
The model for end‐stage liver disease‐based Japan Integrated Scoring system may have a better predictive ability for patients with hepatocellular carcinoma undergoing locoregional therapy
inferred← citeshttps://doi.org/10.1002/cncr.23185openalex-snapshot
Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization
inferred← citeshttps://doi.org/10.1002/cncr.23878openalex-snapshot
A new prognostic score system in patients with advanced hepatocellular carcinoma not amendable to locoregional therapy
inferred← citeshttps://doi.org/10.1002/cncr.24031openalex-snapshot
High serum des‐gamma‐carboxy prothrombin level predicts poor prognosis after radiofrequency ablation of hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/cncr.24904openalex-snapshot
In‐hospital mortality from liver resection for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/cncr.25791openalex-snapshot
V‐CLIP: Integrating plasma vascular endothelial growth factor into a new scoring system to stratify patients with advanced hepatocellular carcinoma for clinical trials
inferred← citeshttps://doi.org/10.1002/cncr.26561openalex-snapshot
Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus
inferred← citeshttps://doi.org/10.1002/cncr.26726openalex-snapshot
A study of circulating interleukin 10 in prognostication of unresectable hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/cncr.27800openalex-snapshot
Hospital volume of percutaneous radiofrequency ablation is closely associated with treatment outcomes for patients with hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/cncr.28209openalex-snapshot
Modified cisplatin/interferon α‐2b/doxorubicin/5‐fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability, and survival of initially unresectable hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/cncr.28730openalex-snapshot
The clinical management of hepatocellular carcinoma in the United States, Europe, and Asia: A comprehensive and evidence‐based comparison and review
inferred← citeshttps://doi.org/10.1002/cncr.29275openalex-snapshot
Open‐label prospective study of the safety and efficacy of glass‐based yttrium 90 radioembolization for infiltrative hepatocellular carcinoma with portal vein thrombosis
inferred← citeshttps://doi.org/10.1002/cncr.35720openalex-snapshot
Meta‐analysis of randomized controlled trials of external‐beam radiation versus transarterial chemoembolization for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/ctm2.70224openalex-snapshot
Spatial‒temporal heterogeneities of liver cancer and the discovery of the invasive zone
inferred← citeshttps://doi.org/10.1002/elps.201700025openalex-snapshot
LC‐MS/MS isomeric profiling of permethylated N‐glycans derived from serum haptoglobin of hepatocellular carcinoma (HCC) and cirrhotic patients
inferred← citeshttps://doi.org/10.1002/hep.1840380430openalex-snapshot
MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: An explant correlation
inferred← citeshttps://doi.org/10.1002/hep.20050openalex-snapshot
Prognostic prediction in HCC: Did anybody expect it to be easy?
inferred← citeshttps://doi.org/10.1002/hep.20072openalex-snapshot
A common staging system for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/hep.20375openalex-snapshot
Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling
inferred← citeshttps://doi.org/10.1002/hep.20486openalex-snapshot
Validation of A New Prognostic Staging System for Hepatocellular Carcinoma: the Jis Score Compared With the Clip Score
inferred← citeshttps://doi.org/10.1002/hep.20583openalex-snapshot
Staging for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/hep.20636openalex-snapshot
Prognosis of hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/hep.20849openalex-snapshot
Staging of Hepatocellular Carcinoma *
inferred← citeshttps://doi.org/10.1002/hep.20933openalex-snapshot
Management of Hepatocellular Carcinoma *
inferred← citeshttps://doi.org/10.1002/hep.21415openalex-snapshot
Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis
inferred← citeshttps://doi.org/10.1002/hep.21468openalex-snapshot
Long-acting octreotide versus placebo for treatment of advanced HCC: A randomized controlled double-blind study
inferred← citeshttps://doi.org/10.1002/hep.21572openalex-snapshot
Hepatitis B viral load predicts survival of HCC patients undergoing systemic chemotherapy
inferred← citeshttps://doi.org/10.1002/hep.21914openalex-snapshot
Does hepatitis B viral load determine the outcome of patients with hepatocellular carcinoma undergoing chemotherapy?
inferred← citeshttps://doi.org/10.1002/hep.22160openalex-snapshot
Identification of metastasis-related microRNAs in hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/hep.22201openalex-snapshot
Blocking transforming growth factor–beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells
inferred← citeshttps://doi.org/10.1002/hep.22432openalex-snapshot
Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: Implications for follow-up and screening
inferred← citeshttps://doi.org/10.1002/hep.23485openalex-snapshot
A meta‐analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma†
inferred← citeshttps://doi.org/10.1002/hep.23725openalex-snapshot
Loco‐regional treatment of hepatocellular carcinoma†
inferred← citeshttps://doi.org/10.1002/hep.24246openalex-snapshot
Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (<5 cm) hepatocellular carcinomas
inferred← citeshttps://doi.org/10.1002/hep.24644openalex-snapshot
Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy
inferred← citeshttps://doi.org/10.1002/hep.24813openalex-snapshot
Sixty-five gene-based risk score classifier predicts overall survival in hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/hep.25680openalex-snapshot
Model to estimate survival in ambulatory patients with hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/hep.25814openalex-snapshot
Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis
inferred← citeshttps://doi.org/10.1002/hep.25832openalex-snapshot
Resection of hepatocellular cancer ≤2 cm: Results from two Western centers
inferred← citeshttps://doi.org/10.1002/hep.26057openalex-snapshot
Single determination of C-reactive protein at the time of diagnosis predicts long-term outcome of patients with hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/hep.26256openalex-snapshot
The ART of decision making: Retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/hep.26731openalex-snapshot
Immunodominance and functional alterations of tumor-associated antigen-specific CD8+ T-cell responses in hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/hep.26944openalex-snapshot
Hepatocellular carcinoma screening in patients with compensated hepatitis C virus (HCV)-related cirrhosis aware of their HCV status improves survival: A modeling approach
inferred← citeshttps://doi.org/10.1002/hep.27264openalex-snapshot
Discovery and validation of urinary metabotypes for the diagnosis of hepatocellular carcinoma in West Africans
inferred← citeshttps://doi.org/10.1002/hep.29714openalex-snapshot
Breaking Kuhn's paradigm in advanced hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/hep.29748openalex-snapshot
Staging for hepatocellular carcinoma in light of tumor heterogeneity: Time to change or update?
inferred← citeshttps://doi.org/10.1002/hep.29883openalex-snapshot
Hepatic resection compared to chemoembolization in intermediate‐ to advanced‐stage hepatocellular carcinoma: A meta‐analysis of high‐quality studies
inferred← citeshttps://doi.org/10.1002/hep.30244openalex-snapshot
Hepatocellular Carcinoma Detection by Plasma Methylated DNA: Discovery, Phase I Pilot, and Phase II Clinical Validation
inferred← citeshttps://doi.org/10.1002/hep.30490openalex-snapshot
An Eastern Hepatobiliary Surgery Hospital/Portal Vein Tumor Thrombus Scoring System as an Aid to Decision Making on Hepatectomy for Hepatocellular Carcinoma Patients With Portal Vein Tumor Thrombus
inferred← citeshttps://doi.org/10.1002/hep.31013openalex-snapshot
Serum Bioavailable, Rather Than Total, 25‐hydroxyvitamin D Levels Are Associated With Hepatocellular Carcinoma Survival
inferred← citeshttps://doi.org/10.1002/hep.31175openalex-snapshot
Biomarkers for Hepatobiliary Cancers
inferred← citeshttps://doi.org/10.1002/hep.31187openalex-snapshot
Treatment of Hepatocellular Carcinoma in the Precision Medicine Era: From Treatment Stage Migration to Therapeutic Hierarchy
inferred← citeshttps://doi.org/10.1002/hep.31325openalex-snapshot
Surgical Treatments of Hepatobiliary Cancers
inferred← citeshttps://doi.org/10.1002/hep.31424openalex-snapshot
Local and Regional Therapies for Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1002/hep.31555openalex-snapshot
HepatoScore‐14: Measures of Biological Heterogeneity Significantly Improve Prediction of Hepatocellular Carcinoma Risk
inferred← citeshttps://doi.org/10.1002/hep.31621openalex-snapshot
Letter to the Editor: Comment on “HepatoScore‐14: Measures of Biological Heterogeneity Significantly Improve Prediction of Hepatocellular Carcinoma Risk”
inferred← citeshttps://doi.org/10.1002/hep.32240openalex-snapshot
Quality measures in HCC care by the Practice Metrics Committee of the American Association for the Study of Liver Diseases
inferred← citeshttps://doi.org/10.1002/hep.32284openalex-snapshot
Overdiagnosis of hepatocellular carcinoma: Prevented by guidelines?
inferred← citeshttps://doi.org/10.1002/hep.32308openalex-snapshot
Ultrasensitive and affordable assay for early detection of primary liver cancer using plasma cell‐free DNA fragmentomics
inferred← citeshttps://doi.org/10.1002/hep.510310111openalex-snapshot
Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/hep4.1014openalex-snapshot
Screening for hepatocellular carcinoma: What is missing?
inferred← citeshttps://doi.org/10.1002/hep4.1046openalex-snapshot
Current guidelines for chemoembolization for hepatocellular carcinoma: Room for improvement?
inferred← citeshttps://doi.org/10.1002/hep4.1277openalex-snapshot
Racial Disparities in Liver Transplantation for Hepatocellular Carcinoma Are Not Explained by Differences in Comorbidities, Liver Disease Severity, or Tumor Burden
inferred← citeshttps://doi.org/10.1002/hep4.1365openalex-snapshot
Hepatocellular Carcinoma Xenografts Established From Needle Biopsies Preserve the Characteristics of the Originating Tumors
inferred← citeshttps://doi.org/10.1002/hep4.1535openalex-snapshot
Primary Treatment with Molecular‐Targeted Agents for Hepatocellular Carcinoma: A Propensity Score‐matching Analysis
inferred← citeshttps://doi.org/10.1002/hep4.1652openalex-snapshot
A Real‐World Observational Cohort of Patients with Hepatocellular Carcinoma: Design and Rationale for TARGET‐HCC
inferred← citeshttps://doi.org/10.1002/hep4.1836openalex-snapshot
Proposal and Validation of a Novel Scoring System for Hepatocellular Carcinomas Beyond Curability Borders
inferred← citeshttps://doi.org/10.1002/ijc.22616openalex-snapshot
Validation of clinical AJCC/UICC TNM staging system for hepatocellular carcinoma: Analysis of 5,613 cases from a medical center in southern Taiwan
inferred← citeshttps://doi.org/10.1002/ijc.29394openalex-snapshot
Multicenter analysis of soluble A xl reveals diagnostic value for very early stage hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/ijc.31991openalex-snapshot
Serum copper and zinc levels at diagnosis and hepatocellular carcinoma survival in the Guangdong Liver Cancer Cohort
inferred← citeshttps://doi.org/10.1002/ijc.33545openalex-snapshot
Sarcomatoid hepatocellular carcinoma is distinct from ordinary hepatocellular carcinoma: Clinicopathologic, transcriptomic and immunologic analyses
inferred← citeshttps://doi.org/10.1002/ijc.33829openalex-snapshot
Circulating DNA changes are predictive of disease progression after transarterial chemoembolization
inferred← citeshttps://doi.org/10.1002/ijc.33993openalex-snapshot
Targeting population groups with heavier burden of hepatocellular carcinoma incidence: A nationwide descriptive epidemiological study in Sweden
inferred← citeshttps://doi.org/10.1002/ijc.34045openalex-snapshot
The combined signatures of hypoxia and cellular landscape provides a prognostic and therapeutic biomarker in hepatitis B virus‐related hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/ijc.70204openalex-snapshot
Circulating cell‐free DNA methylation biomarkers for hepatocellular carcinoma risk prediction in HIV ‐positive Nigerian population
inferred← citeshttps://doi.org/10.1002/ijgo.12888openalex-snapshot
Short‐term efficacy, safety, and cost‐effectiveness of transarterial chemoembolization with drug‐eluting beads versus synchronous radiochemotherapy for cervical cancer
inferred← citeshttps://doi.org/10.1002/jcb.26884openalex-snapshot
Competing endogenous RNA network crosstalk reveals novel molecular markers in colorectal cancer
inferred← citeshttps://doi.org/10.1002/jcb.27125openalex-snapshot
The Nogo‐B receptor promotes human hepatocellular carcinoma cell growth via the Akt signal pathway
inferred← citeshttps://doi.org/10.1002/jcb.28045openalex-snapshot
circRNAs (hsa_circ_00156, hsa_circ _000224, and hsa_circ _000520) are novel potential biomarkers in hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/jcla.20491openalex-snapshot
Screening serum biomarkers for early primary hepatocellular carcinoma using a phage display technique
inferred← citeshttps://doi.org/10.1002/jcla.24296openalex-snapshot
Validation of the hepatocellular carcinoma early detection screening algorithm Doylestown and aMAP in a cohort of Chinese with cirrhosis
inferred← citeshttps://doi.org/10.1002/jcu.10151openalex-snapshot
Contrast‐enhanced power Doppler sonography and helical computed tomography for assessment of vascularity of small hepatocellular carcinomas before and after percutaneous ablation
inferred← citeshttps://doi.org/10.1002/jgh3.12096openalex-snapshot
Specific adverse events predict survival rates in a Chinese population diagnosed with hepatocellular carcinoma and treated with sorafenib
inferred← citeshttps://doi.org/10.1002/jgh3.12102openalex-snapshot
Nomogram predicting extrahepatic metastasis of hepatocellular carcinoma based on commonly available clinical data
inferred← citeshttps://doi.org/10.1002/jgh3.12408openalex-snapshot
Sorafenib as second‐line treatment option after failure of lenvatinib in patients with unresectable hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/jgh3.12420openalex-snapshot
Early radiological response evaluation with response evaluation criteria in solid tumors 1.1 stratifies survival in hepatocellular carcinoma patients treated with lenvatinib
inferred← citeshttps://doi.org/10.1002/jgh3.12676openalex-snapshot
Combination of psoas muscle mass index and neutrophil/lymphocyte ratio as a prognostic predictor for patients undergoing nonsurgical hepatocellular carcinoma therapy
inferred← citeshttps://doi.org/10.1002/jgh3.12705openalex-snapshot
Potential of PALBI‐T score as a prognostic model for hepatocellular carcinoma in alcoholic liver disease
inferred← citeshttps://doi.org/10.1002/jgh3.12735openalex-snapshot
Conversion surgery for hepatocellular carcinoma after tyrosine kinase inhibitor treatment
inferred← citeshttps://doi.org/10.1002/jhbp.1087openalex-snapshot
Outcome of major hepatectomy in cirrhotic patients; does surgical approach matter? A propensity score matched analysis
inferred← citeshttps://doi.org/10.1002/jhbp.1135openalex-snapshot
Conversion surgery after preoperative therapy for advanced hepatocellular carcinoma in the era of molecular targeted therapy and immune checkpoint inhibitors
inferred← citeshttps://doi.org/10.1002/jhbp.1164openalex-snapshot
The ratio of creatinine and cystatin C estimated glomerular filtration rates as a surrogate marker in patients with hepatocellular carcinoma undergoing hepatic resection
inferred← citeshttps://doi.org/10.1002/jhbp.124openalex-snapshot
Influence of clinically significant portal hypertension on surgical outcomes and survival following hepatectomy for hepatocellular carcinoma: a systematic review and meta‐analysis
inferred← citeshttps://doi.org/10.1002/jhbp.436openalex-snapshot
Survival benefit of hepatic resection for hepatocellular carcinoma beyond the Barcelona Clinic Liver Cancer classification
inferred← citeshttps://doi.org/10.1002/jhbp.597openalex-snapshot
Validation of the albumin–indocyanine green evaluation model in patients with resected hepatocellular carcinoma and comparison with the albumin–bilirubin score
inferred← citeshttps://doi.org/10.1002/jhbp.602openalex-snapshot
Impact of pretreatments on outcomes after living donor liver transplantation for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/jhbp.736openalex-snapshot
Reappraisal of the advantages of laparoscopic liver resection for intermediate hepatocellular carcinoma within a stage migration perspective: Propensity score analysis of the differential benefit
inferred← citeshttps://doi.org/10.1002/jmri.22588openalex-snapshot
Additional value of gadoxetic acid‐DTPA‐enhanced hepatobiliary phase MR imaging in the diagnosis of early‐stage hepatocellular carcinoma: Comparison with dynamic triple‐phase multidetector CT imaging
inferred← citeshttps://doi.org/10.1002/jmri.24465openalex-snapshot
Response stratification and survival analysis of hepatocellular carcinoma patients treated with intra‐arterial therapy using MR imaging‐based arterial enhancement fraction
inferred← citeshttps://doi.org/10.1002/jmri.27258openalex-snapshot
Editorial for “ MRI ‐based Radiomics: Potential Abilities for Individual Preoperative Predictions of the Recurrence‐Free Survival of Patients With Hepatocellular Carcinoma Treated With Conventional Transcatheter Arterial Chemoembolization”
inferred← citeshttps://doi.org/10.1002/jmv.24078openalex-snapshot
Hepatitis B surface antigen in late hepatitis B infection
inferred← citeshttps://doi.org/10.1002/jmv.24187openalex-snapshot
Lack of evidence that adherence to standard of care therapy improves survival in subjects with hepatocellular carcinoma in clinical practice
inferred← citeshttps://doi.org/10.1002/jmv.24217openalex-snapshot
HBeAg-negative chronic hepatitis patients should be monitored more strictly: A cross-sectional retrospective study on antiviral treatment-naïve patients
inferred← citeshttps://doi.org/10.1002/jmv.24828openalex-snapshot
Molecular analysis of Hepatitis B virus sub‐genotypes and incidence of preS1/preS2 region mutations in HBV‐infected Egyptian patients from Mansoura
inferred← citeshttps://doi.org/10.1002/jmv.25428openalex-snapshot
Frequency and Implications of myeloid‐derived suppressor cells and lymphocyte subsets in Egyptian patients with hepatitis C virus‐related hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/jso.20999openalex-snapshot
Mitotic checkpoint gene MAD1 in hepatocellular carcinoma is associated with tumor recurrence after surgical resection
inferred← citeshttps://doi.org/10.1002/jso.21159openalex-snapshot
Treatment and prognosis of hepatocellular carcinoma: A population based study in France
inferred← citeshttps://doi.org/10.1002/jso.21364openalex-snapshot
Liver tumor ablation: Percutaneous and open approaches
inferred← citeshttps://doi.org/10.1002/jso.21506openalex-snapshot
Recent advances in the management of primary hepatic tumors refinement of surgical techniques and effect on outcome
inferred← citeshttps://doi.org/10.1002/jso.21512openalex-snapshot
Favorable long‐term surgical outcomes of hepatocellular carcinoma in patients with hepatitis B envelope antibody
inferred← citeshttps://doi.org/10.1002/jso.21776openalex-snapshot
Targeting the growth factors and angiogenesis pathways: Small molecules in solid tumors
showing the first 200 of 3748 · page through all 3748
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.